Xiao Z.

Xiao Z. is a research scientist at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, affiliated with the National Center for Tumor Diseases. Their research focuses on molecular oncology, particularly in the areas of cancer genomics, bioinformatics, and immunotherapy.

Xiao Z.'s research interests span multiple cancer types with emphasis on soft tissue sarcomas and medulloblastoma. Their work integrates bioinformatics analysis with experimental validation to identify prognostic biomarkers and understand epigenetic mechanisms driving cancer progression. Recent publications demonstrate expertise in tumor immunology, chromatin modification abnormalities, and CRISPR screening data analysis.

Their publication record shows a strong focus on identifying therapeutic targets and understanding resistance mechanisms, particularly in immunotherapy contexts. The research trajectory indicates increasing specialization in molecular mechanisms of cancer progression with translational applications.

Xiao Z. has contributed to multiple high-impact publications in journals including Cell Reports, npj Precision Oncology, and Developmental Cell, demonstrating collaborative research across international teams.